Pear Therapeutics, Inc.: long_term_debt

Value{"amount": 39212000, "concept": "us-gaap:LongTermDebt", "currency": "USD"}
Period (as of 2022-09-30)
Statuscurrent
EntityPear Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001835567-22-000076 · Open the official SEC filing →
Retrieved: 2026-08-19T18:29:14.646643+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001835567/long-term-debt/2022-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/5f3bf688-17d7-4993-8f2e-41f96f95e3f9

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies